Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nadiya Hussain, Muntaha Naeem & David J. Pinato. (2021) Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?. Human Vaccines & Immunotherapeutics 17:1, pages 55-61.
Read now
Read now
Articles from other publishers (58)
Hongda Zhu, Kai Ma, Rui Ruan, Chaobo Yang, Aqin Yan, Jing Li, Qi Yu, Hongmei Sun, Mingxing Liu, Hongmei Zheng, Jing Gao, Xiaofang Guan, Zhu Dai & Yao Sun. (2024) Tumor-targeted self-assembled micelles reducing PD-L1 expression combined with ICIs to enhance chemo-immunotherapy of TNBC. Chinese Chemical Letters 35:2, pages 108536.
Crossref
Crossref
Li Wang & Zhe Zhang. (2023) Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms. Journal of Diabetes Research 2023, pages 1-14.
Crossref
Crossref
Mehmet Akce, Batoul Farran, Jeffrey M Switchenko, Manali Rupji, Sandra Kang, Lana Khalil, Amanda Ruggieri-Joyce, Brian Olson, Walid L Shaib, Christina Wu, Olatunji B Alese, Maria Diab, Gregory B Lesinski & Bassel F El-Rayes. (2023) Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer 11:10, pages e007235.
Crossref
Crossref
Hao Tian, Wenxi Li, Guohao Wang, Ye Tian, Jie Yan, Songtao Zhou, Xinying Yu, Bei Li & Yunlu Dai. (2023)
Self‐Degradable Nanogels Reshape Immunosuppressive Tumor Microenvironment via Drug Repurposing Strategy to Reactivate Cytotoxic CD8
+
T Cells
. Advanced Science 10:21.
Crossref
Crossref
Ryan C. Augustin, Ziyu Huang, Fei Ding, Shuyan Zhai, Jennifer McArdle, Anthony Santisi, Michael Davis, Cindy Sander, Diwakar Davar, John M. Kirkwood, Greg M. Delgoffe, Allison Betof Warner & Yana G. Najjar. (2023) Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study. Frontiers in Oncology 13.
Crossref
Crossref
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, Adam Enver Frampton, Giovanni Vennarecci, Stylianos Kykalos, Dimitrios Schizas, Stamatios Theocharis & Nikolaos Machairas. (2023) The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?. Cancers 15:12, pages 3161.
Crossref
Crossref
Zainab Fatima, Abdulrahman Abonofal & Bettzy Stephen. (2023) Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors. Journal of Immunotherapy and Precision Oncology 6:2, pages 91-102.
Crossref
Crossref
Constantinos Savva, Ellen Copson, Peter W. M. Johnson, Ramsey I. Cutress & Stephen A. Beers. (2023) Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies. Cancers 15:9, pages 2440.
Crossref
Crossref
Julien Colard-Thomas, Quentin Dominique Thomas & Marie Viala. (2023) Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications. Cancers 15:8, pages 2276.
Crossref
Crossref
Lingna Li, Jianing Huang, Tongmin Huang, Jie Yao, Yeyuan Zhang, Meiling Chen, Haojie Shentu & Haiying Lou. (2023) Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies. International Journal of Endocrinology 2023, pages 1-10.
Crossref
Crossref
Nhat-Chau TRUONG, Nhi-Thao HUYNH, Kmuong-Duy PHAM & Phuc-Van PHAM. (2023) Roles of cancer stem cells in cancer immune surveillance. Minerva Biotechnology and Biomolecular Research 35:1.
Crossref
Crossref
Yi Zhang, Fang Zhou, Jiaheng Guan, Lukun Zhou & Baoan Chen. (2023) Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review. Biomolecules 13:2, pages 250.
Crossref
Crossref
Eslam E. Abd El-Fattah. (2023) Tumor lysis syndrome promotes cancer chemoresistance and relapse through AMPK inhibition. International Immunopharmacology 114, pages 109568.
Crossref
Crossref
Xiao-yu Wu, Wen-Wen Xu, Xiang-kun Huan, Guan-nan Wu, Gang Li, Yu-Hong Zhou & Masoud Najafi. (2022) Mechanisms of cancer cell killing by metformin: a review on different cell death pathways. Molecular and Cellular Biochemistry 478:1, pages 197-214.
Crossref
Crossref
Yang Du, Ya-Juan Zhu, Yi-Xin Zhou, Jing Ding & Ji-Yan Liu. (2022) Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study. Molecular Biomedicine 3:1.
Crossref
Crossref
Samaneh Mostafavi, Hamidreza Zalpoor & Zuhair Mohammad Hassan. (2022) The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors. Cellular & Molecular Biology Letters 27:1.
Crossref
Crossref
Maria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, Elisa Marabotto, Mario Strazzabosco & Edoardo G. Giannini. (2022) Diabetes medications and risk of HCC. Hepatology 76:6, pages 1880-1897.
Crossref
Crossref
Yifan Wang, Jingguo Hu, Yu Sun, Bo Song, Yan Zhang, Yusong Lu & Haitao Ma. (2022) Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-9.
Crossref
Crossref
Zihong Wu, Caidie Zhang & Masoud Najafi. (2021) Targeting of the tumor immune microenvironment by metformin. Journal of Cell Communication and Signaling 16:3, pages 333-348.
Crossref
Crossref
Hyunkyung Kim, Dohyeon Kim, Wonwoo Kim, EunJi Kim, Won Il Jang & Mi-Sook Kim. (2022) The Efficacy of Radiation is Enhanced by Metformin and Hyperthermia Alone or Combined Against FSaII Fibrosarcoma in C3H Mice. Radiation Research 198:2.
Crossref
Crossref
Eslam E. Abd El-Fattah & Amr Y. Zakaria. (2022) Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach. International Immunopharmacology 109, pages 108889.
Crossref
Crossref
Chang W. Song, Hyunkyung Kim, Haeun Cho, Mi-Sook Kim, Sun-Ha Paek, Heon-Joo Park, Robert J. Griffin, Stephanie Terezakis & Lawrence Chinsoo Cho. (2022) HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR). Cancers 14:13, pages 3273.
Crossref
Crossref
Raymond Chang. 2022. Drug Repurposing - Molecular Aspects and Therapeutic Applications. Drug Repurposing - Molecular Aspects and Therapeutic Applications.
Stella Papachristou, Djordje S. Popovic & Nikolaos Papanas. (2022) Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?. Advances in Therapy 39:6, pages 2283-2286.
Crossref
Crossref
Mónica Cejuela, Begoña Martin-Castillo, Javier A. Menendez & Sonia Pernas. (2022) Metformin and Breast Cancer: Where Are We Now?. International Journal of Molecular Sciences 23:5, pages 2705.
Crossref
Crossref
Wataru Goto, Shinichiro Kashiwagi, Yuri Kamei, Chika Watanabe, Naoki Aomatsu, Katsumi Ikeda, Yoshinari Ogawa, Kosei Hirakawa & Masaichi Ohira. (2022) Relationship between serum lipid levels and the immune microenvironment in breast cancer patients: a retrospective study. BMC Cancer 22:1.
Crossref
Crossref
Mohammed Yunus, Amr Zaher, Sajid Hussain, Karam Ali Alawami, Dhiyaa Jaber Alfaraj, Ahmed Mohammed Alqatari, Morteda Jasim Alsalim, Murtaja Zaki Almissri & Mohammed Abdul Lateef Junaid. (2022) Assessing the anticancer effects of metformin. F1000Research 11, pages 431.
Crossref
Crossref
Mohammed Yunus, Amr Zaher, Sajid Hussain, Karam Ali Alawami, Dhiyaa Jaber Alfaraj, Ahmed Mohammed Alqatari, Morteda Jasim Alsalim, Murtaja Zaki Almissri & Mohammed Abdul Lateef Junaid. (2022) Assessing the anticancer effects of metformin. F1000Research 11, pages 431.
Crossref
Crossref
Yuping Jiang, Yulong Tan, Kefeng Xiao, Xiaoshuang Li, Kai Shao, Junyao Song, Xiaoying Kong & Jinsheng Shi. (2021) pH-Regulating Nanoplatform for the “Double Channel Chase ” of Tumor Cells by the Synergistic Cascade between Chlorine Treatment and Methionine-Depletion Starvation Therapy. ACS Applied Materials & Interfaces 13:46, pages 54690-54705.
Crossref
Crossref
Yao Lu, Dao Xin, Lulu Guan, Mengli Xu, Yalan Yang, Yu Chen, Yuanyuan Yang, Andrea Wang-Gillam, Li Wang, Shanggang Zong & Feng Wang. (2021) Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway. Frontiers in Oncology 11.
Crossref
Crossref
Luis Enrique Munoz, Lei Huang, Ramireddy Bommireddy, Richa Sharma, Lenore Monterroza, Rohini N. Guin, Sarah G. Samaranayake, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Mala Shanmugam & Periasamy Selvaraj. (2021) Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy. Journal for ImmunoTherapy of Cancer 9:11, pages e002614.
Crossref
Crossref
Danielle Brain, Alex Plant-Hately, Bethany Heaton, Usman Arshad, Christopher David, Christian Hedrich, Andrew Owen & Neill J. Liptrott. (2021) Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Advanced Drug Delivery Reviews 178, pages 113848.
Crossref
Crossref
Carolyn T. Bramante, John Buse, Leonardo Tamaritz, Ana Palacio, Ken Cohen, Deneen Vojta, David Liebovitz, Nia Mitchell, Jacinda Nicklas, Ildiko Lingvay, Jeanne M. Clark, Louis J. Aronne, Erik Anderson, Michael Usher, Ryan Demmer, Genevieve B. Melton, Nicholas Ingraham & Christopher J. Tignanelli. (2021) Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity. Journal of Medical Virology 93:7, pages 4273-4279.
Crossref
Crossref
Steffen M. Heckl, Franziska Mau, Anke Senftleben, Tina Daunke, Silje Beckinger, Samir Abdullazade, Stefan Schreiber, Christoph Röcken, Susanne Sebens & Heiner Schäfer. (2021) Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control. Medical Sciences 9:3, pages 48.
Crossref
Crossref
Ademar Dantas Cunha Júnior, Arinilda Campos Bragagnoli, Felipe Osório Costa & José Barreto Campello Carvalheira. (2021) Repurposing metformin for the treatment of gastrointestinal cancer. World Journal of Gastroenterology 27:17, pages 1883-1904.
Crossref
Crossref
Jeonghyeon Moon, Seon-yeong Lee, Jeong Won Choi, A Ram Lee, Jin Hee Yoo, Su-Jin Moon, Sung-Hwan Park & Mi-La Cho. (2021) Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts. Journal of Translational Medicine 19:1.
Crossref
Crossref
Wei-Kai Wu, Ekaterina A. Ivanova & Alexander N. Orekhov. (2021) Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer. Seminars in Cancer Biology 70, pages 85-97.
Crossref
Crossref
Georgina R. Jones & Mark P. Molloy. (2020) Metformin, Microbiome and Protection Against Colorectal Cancer. Digestive Diseases and Sciences 66:5, pages 1409-1414.
Crossref
Crossref
Rola El Sayed, Yolla Haibe, Ghid Amhaz, Youssef Bouferraa & Ali Shamseddine. (2021) Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?. International Journal of Molecular Sciences 22:4, pages 2142.
Crossref
Crossref
Elisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo & Javier A. Menendez. (2021) Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology. Frontiers in Oncology 10.
Crossref
Crossref
Wenhui Liu, Ying Wang, Jianquan Luo, Mouze Liu & Zhiying Luo. (2021) Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors. Frontiers in Immunology 11.
Crossref
Crossref
Ademar Dantas da Cunha Júnior, Dalila Luciola Zanette, Fernando Vieira Pericole, Sara Teresinha Olalla Saad & José Barreto Campello Carvalheira. (2021) Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?. Advances in Hematology 2021, pages 1-7.
Crossref
Crossref
Mariana Segovia-Mendoza, Susana Romero-Garcia, Cristina Lemini & Heriberto Prado-Garcia. (2021) Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation. Journal of Immunology Research 2021, pages 1-18.
Crossref
Crossref
Asimina Koulouridi, Ippokratis Messaritakis, Nikolaos Gouvas, John Tsiaoussis & John Souglakos. (2020) Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer. Cancers 13:1, pages 43.
Crossref
Crossref
Yingying Cui, Jing Zhou & Fengnian Rong. (2020) Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/AKT/mTOR pathway. Biochemical and Biophysical Research Communications 533:4, pages 665-671.
Crossref
Crossref
Yang Xiong, Wantong Song, Limei Shen, Ying Wang, Jing Zhang, Mengying Hu, Yun Liu, Jingjing Li, Sara Musetti, Rihe Liu & Leaf Huang. (2020) Oral Metformin and Polymetformin Reprogram Immunosuppressive Microenvironment and Boost Immune Checkpoint Inhibitor Therapy in Colorectal Cancer. Advanced Therapeutics 3:12, pages 2000168.
Crossref
Crossref
KyeongJin Kim, Wen-Hao Yang, Youn-Sang Jung & Jong-ho Cha. (2020) A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity. BMB Reports 53:10, pages 512-520.
Crossref
Crossref
Shuhong Wang, Yusheng Lin, Xiao Xiong, Lu Wang, Yi Guo, Yuping Chen, Shaobin Chen, Geng Wang, Peng Lin, Hongcai Chen, Sai-Ching Jim Yeung, Edwin Bremer & Hao Zhang. (2020) Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clinical Cancer Research 26:18, pages 4921-4932.
Crossref
Crossref
George G. Chen, Peter Y.M. Woo, Stephanie C.P. Ng, George K.C. Wong, Danny T.M. Chan, Charles A. van Hasselt, Michael C.F. Tong & Wai Sang Poon. (2020) Impact of metformin on immunological markers: Implication in its anti-tumor mechanism. Pharmacology & Therapeutics 213, pages 107585.
Crossref
Crossref
Dinesh Keerty, Viktoriya Koverzhenko, Dalila Belinc, Katie LaPorta & Elizabeth Haynes. (2020) Immune-Mediated Toxic Epidermal Necrolysis. Cureus.
Crossref
Crossref
Elisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo, Tomás Alarcón, Ruth Lupu, Joaquim Bosch-Barrera & Javier A. Menendez. (2020) Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy. Cancers 12:7, pages 1757.
Crossref
Crossref
Huang-Yu Yang, Chao-Yi Wu, Jonathan D. Powell & Kun-Lin Lu. (2020) Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical Perspective. International Journal of Molecular Sciences 21:11, pages 4030.
Crossref
Crossref
Javier A. Menendez. (2020) Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19. Aging 12:10, pages 8760-8765.
Crossref
Crossref
Javier A. Menendez. (2020) Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity. Biomolecules 10:5, pages 780.
Crossref
Crossref
Mark Williams, Xinhui Liu, Yueqi Zhang, Jake Reske, Devika Bahal, Trevor G. Gohl, Daniel Hollern, Elliot Ensink, Matti Kiupel, Rongcheng Luo, Rupali Das & Hua Xiao. (2020) NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21WAF1/CIP1 overexpression, which is reversed by metformin. Oncogene 39:19, pages 3821-3836.
Crossref
Crossref
Kailin Chen, Yajun Li, Zhen Guo, Yong Zeng, Wei Zhang & Hui Wang. (2020) Metformin: current clinical applications in nondiabetic patients with cancer. Aging 12:4, pages 3993-4009.
Crossref
Crossref
Sara Verdura, Elisabet Cuyàs, Eric Cortada, Joan Brunet, Eugeni Lopez-Bonet, Begoña Martin-Castillo, Joaquim Bosch-Barrera, José Antonio Encinar & Javier A. Menendez. (2020) Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity. Aging 12:1, pages 8-34.
Crossref
Crossref
Shouyan Deng, Xiaolin Zhou & Jie Xu. 2020. Regulation of Cancer Immune Checkpoints. Regulation of Cancer Immune Checkpoints
431
453
.